FindMyKOL

Christopher Manley, MD

Basic profile

Fox Chase Cancer Center

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionPhiladelphia, PA · NortheastSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLFindMyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Christopher Manley is a Respiratory physician affiliated with Fox Chase Cancer Center. OpenAlex indexes 35 publications with 430 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
35publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

430citations

Citations across these publications.

9h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
14companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Janssen
    Program year202517 paymentsResearch
    $140,677
  • Ethicon Inc.
    Program year202514 payments
    $32,888
  • Medical Device Business Services, Inc.
    Program year202526 payments
    $7,078
All 31 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    89.5%
    Corticosteroid43.1%
    Trelegy Ellipta37%Symbicort29%Budesonide-Formoterol Fumarate14%Breo Ellipta10%Fluticasone Propionate10%
    Part D<11 patients
    beta2-Adrenergic Agonist38%
    Albuterol Sulfate Hfa84%Ventolin Hfa16%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    5.8%
    Corticosteroid5.8%
    Prednisone100%
    Part D<11 patients
  • Anti-infectives

    4.7%
    Macrolide Antimicrobial4.7%
    Azithromycin100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”